Search research articles
Contact Us
Filters
Showing results (121-130 of 325) with videos related to
Page
of 33
Sort By:
Expert Review of Hematology
|
February 21, 2018
Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia
Neil E Kay, Betsy R LaPlant, Adam M Pettinger, et al.
Journal of Nanobiotechnology
|
May 10, 2007
Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis
Priyabrata Mukherjee, Resham Bhattacharya, Nancy Bone, et al.
International Journal of Cancer
|
March 1, 2021
Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma
Mark Liebow, Melissa C Larson, Carrie A Thompson, et al.
Leukemia Research
|
January 22, 2005
Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia
Stephanie R Fink, Sarah F Paternoster, Stephanie A Smoley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2024
Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2-Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
Murali K Mamidi, Sutapa Sinha, Mariana T Mendez, et al.
American Journal of Hematology
|
April 3, 2016
Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi-institutional study
Daphne R Friedman, Alexander B Sibley, Kouros Owzar, et al.
Cancer
|
February 27, 2010
Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemia
Neil E Kay, Wenting Wu, Brian Kabat, et al.
Cancer
|
September 2, 2008
Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab
Clive S Zent, Timothy G Call, Tait D Shanafelt, et al.
The Journal of Clinical Investigation
|
December 8, 2007
Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients
Renee C Tschumper, Susan M Geyer, Megan E Campbell, et al.
British Journal of Haematology
|
July 14, 2011
Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance
Marek Mraz, Clive S Zent, Amy K Church, et al.
Page
of 33
Search research articles
Search
Showing results (121-130 of 325) with videos related to
Sort By:
Page
of 33
Expert Review of Hematology
|
February 21, 2018
Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia
Neil E Kay, Betsy R LaPlant, Adam M Pettinger, et al.
Journal of Nanobiotechnology
|
May 10, 2007
Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis
Priyabrata Mukherjee, Resham Bhattacharya, Nancy Bone, et al.
International Journal of Cancer
|
March 1, 2021
Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma
Mark Liebow, Melissa C Larson, Carrie A Thompson, et al.
Leukemia Research
|
January 22, 2005
Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia
Stephanie R Fink, Sarah F Paternoster, Stephanie A Smoley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2024
Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2-Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
Murali K Mamidi, Sutapa Sinha, Mariana T Mendez, et al.
American Journal of Hematology
|
April 3, 2016
Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi-institutional study
Daphne R Friedman, Alexander B Sibley, Kouros Owzar, et al.
Cancer
|
February 27, 2010
Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemia
Neil E Kay, Wenting Wu, Brian Kabat, et al.
Cancer
|
September 2, 2008
Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab
Clive S Zent, Timothy G Call, Tait D Shanafelt, et al.
The Journal of Clinical Investigation
|
December 8, 2007
Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients
Renee C Tschumper, Susan M Geyer, Megan E Campbell, et al.
British Journal of Haematology
|
July 14, 2011
Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance
Marek Mraz, Clive S Zent, Amy K Church, et al.
Page
of 33